Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: A systematic review

详细信息	查看全文 | 推荐本文 |

• 作者：Felipe Carvalho de Oliveira^a ; ^b ; Gilson Soares Feitosa-Filho^a ; ^b ; ^{gilsonfeitosafilho@yahoo.com.br} ; Luiz Eduardo Fonteles Ritt^b ; ^c
• 关键词：Cardiopulmonary Resuscitation ; Ventricular fibrillation ; Beta-blockade ; Beta-blockers ; Advanced Life Support
• 刊名：Resuscitation
• 出版年：2012
• 期刊代码：236_03009572
• 类别：med
• 出版时间：June, 2012
• 卷：83
• 期：6
• 页码：674-683
• 文件大小：310 K

摘要

Introduction

Advanced Life Support guidelines recommend the use of epinephrine during Cardiopulmonary Resuscitation (CPR), as to increase coronary blood flow and perfusion pressure through its alpha-adrenergic peripheral vasoconstriction, allowing minimal rises in coronary perfusion pressure to make defibrillation possible. Contrasting to these alpha-adrenergic effects, epinephrine's beta-stimulation may have deleterious effects through an increase in myocardial oxygen consumption and a reduction of subendocardial perfusion, leading to postresuscitation cardiac dysfunction.

Objective

The present paper consists of a systematic review of the literature regarding the use of beta-blockade in cardiac arrest due to ventricular fibrillation (VF) and pulseless ventricular tachycardia (VT).

Methods

Studies were identified through MEDLINE electronic databases research and were included those regarding the use of beta-blockade during CPR.

Results

Beta-blockade has been extensively studied in animal models of CPR. These studies not only suggest that beta-blockade could reduce myocardial oxygen requirements and the number of shocks necessary for defibrillation, but also improve postresuscitation myocardial function, diminish arrhythmia recurrences and prolong survival. A few case reports described successful beta-blockade use in patients, along with two prospective human studies, suggesting that it could be safe and effectively used during cardiac arrest in humans.

Conclusion

Even though the existing literature points toward a beneficial effect of beta-blockade in patients presenting with cardiac arrest due to VF/pulseless VT, high quality human trials are still lacking to answer this question definitely.